Alexion Pharmaceuticals Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
222.86 M |
Public Float |
213.41 M |
Alexion Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.82 |
Market Cap |
$29.22 B |
Shares Outstanding |
224.24 M |
Public Float |
222.46 M |
Address |
121 Seaport Boulevard Boston Massachusetts 02210 United States |
Employees | - |
Website | http://www.alexion.com |
Updated | 07/08/2019 |
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include soliris, strensiq and kanuma. The company was founded by Joseph A. |